SMMT
Summit Therapeutics PLC
15.60$
-4.7%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | -235.6% | – | – | – | – | – | – | – | – | |
| – | +37.5% | +6.1% | +681.0% | +244.8% | -28.7% | +5.7% | +23.7% | -43.4% | -84.8% | -54.6% | +52.4% | |
| – | +14.1% | +4.3% | +32.0% | +176.7% | -91.4% | +139.3% | +631.7% | +2.6% | +14.6% | +264.9% | +1,234.3% | |
| – | -2.2% | -25.1% | -81.8% | +1,103.7% | +26.1% | +2.1% | +197.1% | +91.3% | – | – | – | |
| – | – | +3,675.3% | -82.6% | -891.2% | – | -52.4% | -110.9% | – | -105.1% | – | +88.5% | |
| – | +78.2% | +17.0% | +516.4% | -75.8% | +61.8% | +16.5% | -26.6% | +124.3% | -80.1% | +9.7% | +339.0% | |
| – | -312.7% | +95.0% | +7,320.2% | -95.5% | -63.4% | +155.6% | -26.6% | +124.3% | +91,339.9% | -64.7% | -21.2% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +3,240,965,807,710.7% | +0.0% | +0.0% | -100.0% | – | – | – | – | – | – | – | |
| – | – | +0.0% | -656.5% | +119.5% | +27.3% | – | +0.0% | +0.0% | -104.7% | +305.1% | -100.0% | |
| – | +3.4% | -98.4% | +3,671.8% | +128.6% | -25.6% | +12.1% | +55.6% | +775.4% | -86.5% | +345.0% | +50.4% | |
| – | -48.4% | +104.8% | -176.7% | – | +0.1% | -72.0% | +110.6% | +11,703.8% | -197.1% | – | +231.2% | |
| – | – | – | -241.1% | – | – | – | – | – | – | – | – |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.